Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01240889 · ClinicalTrials.gov registry record · NA
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
A NA study, sponsored by Creighton University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01240889 is a NA study that has completed, run by Creighton University. The registered enrollment target is 60 participants.
The verdict
NCT01240889, a NA study, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study will be a randomized, double blind, placebo-controlled, parallel group study and will include subjects with ragweed-induced seasonal allergic rhinitis.
Interventions
- DRUG Fluticasone
- DRUG Fluticason
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01240889
The ClinicalTrials.gov registry entry for NCT01240889 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fluticasone is the first listed.
NCT01240889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01240889 about?
NCT01240889 is a clinical study titled "Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*". This study will be a randomized, double blind, placebo-controlled, parallel group study and will include subjects with ragweed-induced seasonal allergic rhinitis.
What is the current status of trial NCT01240889?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2010-11. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01240889?
The interventions under investigation include: Fluticasone (DRUG), Fluticason (DRUG).
Who is sponsoring clinical trial NCT01240889?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.